Xu Qian

9PUBLICATIONS
27CO-AUTHORS
Molecular targetsHaematological tumoursGene and molecular therapyPredictive and prognostic markersProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 12, 2026
MMSDH facilitates ACSL4 propionylation to counteract ferroptosis upon hypoxia and impairs PDAC chemotherapy efficacy.

|Sep 02, 2025
Prognostic value of clinicopathological features of diffuse large B-cell lymphoma with bone marrow involvement.

Yuan Jin, Xiaofang Yao, Yahui Zhou

|Jan 22, 2025
Bispecific Aptamer-Drug Conjugates Selectively Eliminate Malignant Hematologic Cells for Treating Acute Myeloid Leukemia.

Xiaodong Li, Jiacheng Dai, Yuenan Shi

|May 22, 2023
Integration and viral oncogene expression of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma and gastric cancer.

Qiang Xu, Haoru Dong, Zhiyu Wang

|Mar 21, 2023
Aptamer-Based Targeted Protein Degradation.

Yuan Liu, Xu Qian, Chunyan Ran

|Dec 23, 2022
Advanced Nanomedicine for High-Risk HPV-Driven Head and Neck Cancer.

Qiang Xu, Ye Chen, Yuan Jin

Pageof 2

Frequent Collaborators

2 joint publications

Weihong Tan

2 joint publications

Yuan Jin

1 joint publications

Meiyu Fang

1 joint publications

Zhiyu Wang